Known as Veppanu, the drug is the first of its kind to get to market. But Arvinas and partner Pfizer are still searching for a new partner to sell it.
Arvinas’ ‘Protac’ breast cancer drug cleared by FDA
<figure><div><img src="https://imgproxy.divecdn.com/xFVDAUb89QQFVPrJL8faaWdXxcY16WqAOJqd9TV5Hi0/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzY5MDAzNjAwLmpwZw==.webp"/></div></figure><p>Known as Veppanu,

Source: BioPharma Dive